查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046934

耳鼻喉科器材市場－全球產業規模、佔有率、趨勢、機會和預測：按類型、最終用戶、地區和競爭對手分類，2021-2031年

ENT Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球耳鼻喉科醫療設備市場預計將從 2025 年的 275.2 億美元成長到 2031 年的 383.1 億美元，複合年成長率為 5.67%。

該市場涵蓋了治療耳鼻喉疾病所需的各種診斷和手術器械。主要成長要素包括與老齡化相關的聽力損失和慢性呼吸系統疾病的日益普遍，這些疾病通常需要手術干預。例如，美國癌症協會預測，到2025年，美國將新增約59,660例口腔癌和咽癌病例，凸顯了對專用手術和診斷器械的迫切需求，以便有效管理複雜的頭頸部疾病。然而，先進醫療設備的高成本對市場構成了重大挑戰。先進的耳鼻喉科工作站和手術導引系統需要大量的資金投入，這限制了它們的普及，尤其是在經濟低度開發地區。不完善的保險報銷體系加劇了這個經濟障礙，導致患者無法獲得必要的治療，阻礙了全球產業的整體發展。

市場概覽
預測期 2027-2031
市場規模：2025年 275.2億美元
市場規模：2031年 383.1億美元
複合年成長率：2026-2031年 5.67%
成長最快的細分市場 醫院
最大的市場 北美洲

市場促進因素

全球聽力障礙和慢性鼻竇炎盛行率的上升是耳鼻喉科醫療設備市場的主要驅動力，顯著擴大了需要聽力學和外科手術干預的患者群體。隨著世界人口老化和環境噪音暴露的增加，聽力障礙的盛行率正在激增，從而對助聽器和植入等復健解決方案產生了持續而迫切的需求。這種人口結構的變化迫使醫療保健系統加強其診斷和治療能力，直接加速了專業耳鼻喉科設備的普及。世界衛生組織（WHO）在2025年2月報告稱，全球超過5%的人口，即4.3億人，將需要接受聽力損失復健治療，以有效控制這些慢性疾病，這將導致用於有效管理這些慢性疾病的醫療設備處方量增加。此外，微創手術系統和智慧連接技術的創新正在透過改善患者預後和加快產品更換週期來促進市場擴張。業內公司正擴大將人工智慧和無線功能整合到其設備中，從而實現個人化語音處理和高精度手術導引。這些技術進步推動了高階設備的普及，並顯著提升了市場領導者的獲利能力。例如，科利耳有限公司（Cochlear Limited）2025年年度報告顯示，人工電子耳銷售額成長11%，達到14.702億美元，這主要得益於採用新一代連接技術的Nucleus Nexa系統的推出。同樣，索諾瓦（Sonova）2024/25年度報告也強調，其總銷售額達到38.654億瑞士法郎，這主要得益於其最新、最具創新性的助聽器平台的快速普及，這表明這些高科技產品線對整個行業產生了巨大的財務影響。

市場挑戰

全球耳鼻喉科醫療設備市場受到先進診斷和手術設備高昂的購買和營運成本的嚴重限制。醫療機構，尤其是經濟低度開發地區的醫療機構，往往難以籌集投資高性能耳鼻喉科工作站和先進手術導引系統所需的資金。此外，限制性的報銷政策往往無法充分涵蓋此類尖端技術的成本，進一步加劇了這一財務負擔，迫使醫院優先選擇更經濟實惠且必不可少的替代方案，而非先進的解決方案。因此，資金短缺直接阻礙了市場成長，限制了創新設備的普及速度。製造商在進入採購決策主要受預算上限而非臨床療效驅動的市場時面臨挑戰，導致銷售下降和技術普及延遲。根據歐洲醫療技術協會（MedTech Europe）2025年的預測，醫療技術支出將佔醫療保健總支出的約7.7%，但佔GDP的比重將不到1%。對醫療技術的投入如此之低，凸顯了阻礙耳鼻喉科專用設備廣泛普及的經濟負擔，最終扼殺了該行業在已開發市場和新興市場的擴張潛力。

市場趨勢

隨著醫療機構優先考慮最大限度降低交叉感染風險並簡化複雜的再處理流程，一次性耳鼻喉科器械的日益普及正在改變市場格局。醫院正逐步淘汰資本密集的可重複使用內視鏡，轉而採用無菌一次性產品，這些產品能夠確保性能穩定且即時使用，從而減輕與消毒相關的後勤負擔。這種轉變在一次性內視鏡市場的顯著商業性成長中得到了清晰的體現。 Ambu A/S 在 2024 年 11 月的年度報告中指出，其內視鏡解決方案部門實現了 19.7% 的內部成長。這主要得益於耳鼻喉科和泌尿系統領域強勁的兩位數成長，證實了該產業正迅速轉向使用一次性視覺化工具，以提高營運效率和病患安全標準。同時，切除術等高頻手術腺量增殖體顯著地向門診診所和門診手術中心 (ASC) 轉移。這一趨勢的驅動力在於降低醫療成本和提高患者周轉率的需求，即將常規手術從不堪重負的醫院環境轉移到更具成本效益的場所。因此，對能夠在這些更有效率的環境中實現快速治療的技術的需求正在加速成長。根據史密斯醫療（Smith & Nephew）於2025年2月發布的2024年第四季及全年收益報告，耳鼻喉科（ENT）業務核心銷售額成長了19.4%，主要得益於扁桃體和腺量增殖體業務的強勁表現。這一成長凸顯了人們越來越依賴專業的門診機構來高效管理常規耳鼻喉科病例，同時最佳化資源配置。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球耳鼻喉科器械市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（診斷設備、手術設備、助聽器、人工電子耳、鼻夾板、其他）
    • 按最終使用者（醫院、耳鼻喉科診所、門診機構等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美耳鼻喉科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲耳鼻喉科器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太耳鼻喉科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲耳鼻喉科器械市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲耳鼻喉科器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球耳鼻喉科器材市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medtronic Plc
  • Demant A/S
  • Sonova Holdings AG
  • Ambu A/S
  • GN Store Nord A/S
  • Olympus Corporation
  • Starkey Laboratories, Inc.
  • Rion Co., Ltd.
  • Karl Storz Gmbh & Co., KG
  • Stryker Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14826

The Global ENT Devices Market is anticipated to expand from USD 27.52 Billion in 2025 to USD 38.31 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 5.67%. This market comprises a diverse array of diagnostic and surgical instruments essential for treating conditions affecting the ear, nose, and throat. The primary drivers include the increasing prevalence of age-related hearing impairment and chronic respiratory conditions that often necessitate surgical interventions. For instance, the American Cancer Society projected approximately 59,660 new cases of oral cavity and pharynx cancer in the United States in 2025, underscoring the vital need for specialized surgical and diagnostic tools to manage complex head and neck pathologies efficiently. However, the market faces a significant challenge due to the high cost of sophisticated medical instrumentation. The substantial capital investment required for advanced ENT workstations and surgical navigation systems restricts their adoption, particularly in regions with economic limitations. This financial barrier is further compounded by insufficient reimbursement policies, which consequently limit patient access to essential procedures and impede the overall growth of the global industry.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 27.52 Billion
Market Size 2031USD 38.31 Billion
CAGR 2026-20315.67%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Market Driver

The increasing global incidence of both hearing impairment and chronic sinusitis serves as a fundamental catalyst for the ENT devices market, considerably enlarging the patient demographic in need of audiological and surgical interventions. As the world's population ages and exposure to environmental noise escalates, the prevalence of auditory deficits has surged, generating a sustained and urgent demand for rehabilitative solutions like hearing aids and implants. This demographic shift compels healthcare systems to enhance diagnostic capabilities and treatment availability, directly stimulating the acquisition of specialized ENT equipment. The World Health Organization reported in February 2025 that over 5% of the global population, or 430 million people, require rehabilitation for disabling hearing loss, leading to higher volumes of device prescriptions to effectively manage these chronic conditions. Furthermore, technological innovations in minimally invasive surgical systems and smart connectivity are propelling market expansion by improving patient outcomes and accelerating product replacement cycles. Industry players are increasingly integrating artificial intelligence and wireless capabilities into devices, enabling personalized audio processing and highly precise surgical navigation. These advancements encourage the adoption of premium devices, substantially boosting revenue for market leaders. For example, Cochlear Limited's 2025 Annual Report indicated an 11% rise in cochlear implant revenue to $1,470.2 million, largely attributed to the introduction of the Nucleus Nexa System with its next-generation connectivity features. Similarly, Sonova's 2024/25 Annual Report highlighted total sales of CHF 3,865.4 million, supported by the rapid uptake of their latest innovative hearing instrument platforms, illustrating the significant financial impact of such high-tech portfolios across the broader industry.

Market Challenge

The Global ENT Devices Market is significantly hindered by the substantial acquisition and operational expenses associated with advanced diagnostic and surgical instruments. Healthcare facilities, particularly those in economically constrained areas, frequently encounter difficulties in securing the necessary capital to invest in premium ENT workstations and sophisticated surgical navigation systems. This financial burden is exacerbated by restrictive reimbursement policies that often fail to fully cover the cost of these modern technologies, thereby compelling hospitals to prioritize more affordable, essential alternatives over advanced solutions. Consequently, this inadequacy of funding directly impedes market growth by limiting the rate at which innovative devices are adopted. Manufacturers face challenges in penetrating markets where procurement decisions are primarily driven by stringent budgetary caps rather than clinical efficacy, resulting in reduced sales volumes and slower technological integration. According to MedTech Europe in 2025, medical technologies account for approximately 7.7% of total healthcare expenditure, representing less than 1% of GDP; this disproportionately low investment in medical technology highlights the financial strain that prevents the widespread deployment of specialized ENT equipment, ultimately stalling the industry's potential for expansion in both developed and emerging markets.

Market Trends

The increasing adoption of single-use and disposable ENT instruments is transforming the market as healthcare providers prioritize minimizing cross-contamination risks and streamlining complex reprocessing workflows. Hospitals are progressively replacing capital-intensive reusable endoscopes with sterile, disposable alternatives that ensure consistent performance and immediate availability, thereby lessening the logistical demands associated with sterilization. This shift is evident in the substantial commercial growth observed within the disposable endoscopy segment. Ambu A/S reported in its November 2024 Annual Report that its Endoscopy Solutions revenue organically increased by 19.7%, propelled by strong double-digit growth specifically in the ENT and urology segments, underscoring the industry's rapid move towards disposable visualization tools to enhance operational efficiency and patient safety standards. Concurrently, there is a pronounced migration of high-volume procedures, such as tonsillectomies and adenoidectomies, towards Outpatient and Ambulatory Surgical Centers (ASCs). This trend is driven by the imperative to reduce healthcare expenditures and improve patient turnover rates by transferring routine surgeries from overburdened hospital settings to more cost-effective environments. As a result, the demand for technologies that facilitate rapid procedures in these streamlined settings has accelerated. Smith+Nephew's February 2025 Fourth Quarter and Full Year 2024 Results indicated an underlying revenue growth of 19.4% in its ENT division, primarily led by the robust performance of its tonsil and adenoid business. This growth highlights the increasing reliance on specialized outpatient facilities to efficiently manage routine ENT caseloads while optimizing resource allocation.

Key Market Players

  • Medtronic Plc
  • Demant A/S
  • Sonova Holdings AG
  • Ambu A/S
  • GN Store Nord A/S
  • Olympus Corporation
  • Starkey Laboratories, Inc.
  • Rion Co., Ltd.
  • Karl Storz Gmbh & Co., KG
  • Stryker Corporation

Report Scope

In this report, the Global ENT Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ENT Devices Market, By Type

  • Diagnostic Devices
  • Surgical Devices
  • Hearing Aid Devices
  • Hearing Implants
  • Nasal Splints
  • Others

ENT Devices Market, By End User

  • Hospitals
  • ENT Clinics
  • Ambulatory Care Settings
  • Others

ENT Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global ENT Devices Market.

Available Customizations:

Global ENT Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global ENT Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Diagnostic Devices, Surgical Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints, Others)
    • 5.2.2. By End User (Hospitals, ENT Clinics, Ambulatory Care Settings, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America ENT Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States ENT Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada ENT Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico ENT Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe ENT Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany ENT Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France ENT Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom ENT Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy ENT Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain ENT Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia Pacific ENT Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China ENT Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India ENT Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan ENT Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea ENT Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia ENT Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa ENT Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia ENT Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE ENT Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa ENT Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. South America ENT Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil ENT Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia ENT Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina ENT Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global ENT Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic Plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Demant A/S
  • 15.3. Sonova Holdings AG
  • 15.4. Ambu A/S
  • 15.5. GN Store Nord A/S
  • 15.6. Olympus Corporation
  • 15.7. Starkey Laboratories, Inc.
  • 15.8. Rion Co., Ltd.
  • 15.9. Karl Storz Gmbh & Co., KG
  • 15.10. Stryker Corporation

16. Strategic Recommendations

17. About Us & Disclaimer